Mass spectrometric identification of butyrylcholinesterase adducts with organophosphorus compounds using immunoprecipitation from blood plasma
1-Research Institute of Hygiene, Occupational Pathology and Human Eсоlоgy, Federal Medical Biological Agency, Saint Petersburg, Russia.
2-Institute for Analytical Instrumentation RAS, Saint Petersburg, Russia.
3-Institute of Toxicology, Federal Medical Biological Agency, Saint Petersburg, Russia.
Brief summary
Methods of sample preparation and mass spectrometric identification of butyrylcholinesterase (BChE) adducts with organophosphorus compounds (e.g. Russian Vx) were proposed. This approaches allow to determine the contact with Russian Vx (VR) in biological samples with a detection limit of less than 1 ng/ml VR in plasma (for BChE adduct) and less than 5% inhibition of BChE.
1. Kim J.H., Stevens R.C., MacCoss M.J., Goodlett D.R., Scherl A., Richer R.J., Suzuki S.M., Furlong C.E. Identification and characterization of biomarkers of organophosphorous exposures in humans. // Adv Exp Med Biol. – 2010. – V. 660. – P. 61-71.
2. Read R.W., Riches J.R., Stevens J.A., Stubbs S.J., Black R.M. Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy.// Arch.Toxicol. – 2010. – V.84. – P. 25-36.
3. Marsillach J., Richer R.J., Kim J.H.,Stevens R.C., MacCoss M.J., Tomazela D., Suzuki S.M., Schopfer L.M., Lockridge O., Furlong C.E. Biomarkers of organophosphorous exposures in humans // Neurotoxicology. – 2011. – V.32 (5). – P. 656-660.
4. Li H., L.M. Schopfer, F. Nachon, M.T. Froment, P. Masson, O. Lockridge Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry // Toxicological Sciences. – 2007. – V. 100. – P. 136–145.
5. Gomez J.L., Nieto-Ceron S., Campoy F.J., Mundoz-Delgado E., Vidal C.J. Purification and properties of hydrophilic dimers of acetylcholinesterase from mouse erythrocytes. // The International Journal of Biochemistry and Cell Biology. – 2003. – V.35. – P. 1109-1118.
6. Lockridge O., Schopfer L. M., Winger G., Woods J. H. Large scale purification of butyrylcholinesterse from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocain and nerve agent toxicity // J. Med.Chem. Boil. Radiol Def. – 2005. – 3 nihms5095 – PMID: 16788731 – PMCID: PMC1480358.
7. Li H., Tong L., Schopfer L.M., Masson P., Lockridge O. Fast affinity purification coupled with mass spectrometyr for identification organophosphate labeled plasma butyrylcholinesterse // Chem. Biol. Interact. – 2008. – V. 175. – P. 68-72.
8. Li B., I. Ricodel, L.M. Schopfer, F. Baud, B. Megarbane, P. Masson, O. Lockridge. Dichlorvos, chlorpyrifos oxon, aldicarb adducts of butyrylcholiesterase, detected by mass spectrometry, in human plasma following deliberate overdose. // J. Appl Toxicol. – 2010. – V.30. – №6. – P. 559-565.
10. Sporty J.L.S., S.W. Lemire, E.M. Jakubovski, J.A. Renner, R.A. Evans, R.F. Williams, J.G. Schmidt, M.J. vander Schans, D. Noort, R.C. Johnson. Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum. // Anal.Chem. – 2010. – V.82. – P. 6593-6600.
11. Marsillach J., Costa L.G., Furlong C.E. Protein adducts as biomarkers of exposure to organophosphorus compounds. // Toxicology. – 2013. – V. 307. – P. 46-54.
12. Domanski M, Molloy K, Jiang H, Chait BT, Rout MP, Jensen TH, LaCava J. Improved methodology for the affinity isolation of human protein complexes expressed at near endogenous levels. // Biotechniques. – 2012 – P.1-6. – doi:10.2144/000113864. – PubMed PMID: 22668517.